Gallagher Neil Insider Trades

Insider Trading History

Track insider trading activity for Gallagher Neil. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $151k 28,000 shares
Last Trade
Jun 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$114k 28,000 shares
$4.08
$5.38
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $269k 50,000 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$208k 50,000 shares
$4.16
$5.38
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
President, Head Of R&d
Holding Value $2.05M 85,095 shares
Last Trade
Feb 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$71.6k 4,618 shares
$15.50
$24.13
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
President, Head Of R&d
Holding Value $2.67M 110,500 shares
Last Trade
Feb 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.62M 110,500 shares
$14.65
$24.13
Zymeworks BC
Zymeworks BC ZYME
Director
Holding Value $764k 31,000 shares
Last Trade
Dec 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 31,000 shares
$13.06
$24.66
Zymeworks BC
Zymeworks BC ZYME
Director
Holding Value $1.82M 74,000 shares
Last Trade
Apr 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$683k 74,000 shares
$9.23
$24.66
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
President, Head Of R&d
Holding Value $1.67M 69,375 shares
Last Trade
Feb 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.55M 69,375 shares
$22.28
$24.13
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
President, Head Of R&d
Holding Value $6.03M 250,000 shares
Last Trade
Apr 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.84M 250,000 shares
$19.35
$24.13

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up